ESC 365 - Antiplatelet therapy and prognosis at the onset of stent thrombosis

ESC Professional Premium Access

Antiplatelet therapy and prognosis at the onset of stent thrombosis

Session: Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

Topic: Thrombosis, Platelets, and Coagulation

Speaker: Doctor Y. Matsuoka (Osaka, JP)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Yuki Matsuoka

Osaka University Graduate School of Medicine, Osaka (Japan)

0 follower

7 more presentations in this session

The association between the hsCRP/BMI ratio and cardiovascular prognosis in CAD patients

Speaker: Doctor J. Yang (Beijing, CN)

In patients with acute myocardial infarction interleukin-8 levels are related to impaired renal function and predict recurrent infarction or death at 1-year follow-up - a case-control study

Speaker: Mr Y. Wang (Zurich, CH)

Association of inflammatory activation with acute stent thrombosis

Speaker: Doctor K. Krychtiuk (Vienna, AT)

The influence of early post-STEMI inflammation on diastolic function: diagnostic and therapeutic implications

Speaker: Doctor S. Filip (Lyon, FR)

Helicobacter pylori and pro-inflammatory protein biomarkers in myocardial infarction with and without obstructive coronary artery disease

Speaker: Doctor J. Warme (Stockholm, SE)

Access the full session

Markers of inflammation/stenting and stent thrombosis: impact on outcome in acute coronary syndromes

Speakers: Doctor Y. Matsuoka, Doctor J. Yang, Mr Y. Wang, Doctor K. Krychtiuk, Doctor S. Filip...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources